ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Laxmi Dental's 60%-owned Kids-e-Dental received EU MDR and ISO 13485 certificates from TÜV SÜD. The certificates allow EU marketing of its dental products after regulatory formalities.
Laxmi Dental reported record quarterly revenue driven by international expansion and digital adoption.
Laxmi Dental posted record Q2FY27 revenue of Rs 795.2 million, with EBITDA up 38.5% year-on-year. Its consolidated PAT after JV share stood at Rs 100.4 million.
Q2FY27 revenue ₹79.5 Cr (+10% YoY), a record quarter. EBITDA margin 19.2%, PAT ₹10.0 Cr (+17.6%). H1FY27 revenue ₹154.2 Cr (+11.9%).
Laxmi Dental Ltd reported revenue from operations of ₹79.5 Cr (+10.0% YoY) and net profit of ₹10 Cr (+17.6% YoY) for Q2 FY27.
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Laxmi Dental's subsidiary received a tariff refund of ₹5.92 Crore from U.S. Customs following a regulatory change regarding excess tariffs collected.
Laxmi Dental Limited's subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of approximately INR 5.92 Crore from U.S. Customs and Border Protection.
The filing contains the quarterly shareholding pattern for Laxmi Dental Ltd as of September 30, 2026, submitted in compliance with SEBI Regulation 31(1)(b).
Laxmi Dental submitted the Monitoring Agency Report for the quarter ended September 30, 2026, confirming utilization of IPO proceeds is in line with stated objects.
Laxmi Dental Limited approved membership in 'Leelaben Foundation', a Section 8 company, to promote CSR and rural dental facilities. The board also noted compliance fine payments.
Laxmi Dental received NSE and BSE approvals for listing 7,911 ESOP equity shares. The shares will trade from September 18, 2026.
Laxmi Dental Limited has announced its 22nd Annual General Meeting scheduled for September 25, 2026, and submitted its Annual Report for FY 2025-26.
Laxmi Dental Limited has scheduled its 22nd Annual General Meeting for September 25, 2026, via video conferencing. The agenda includes proposed variation of IPO proceeds utilization.
Laxmi Dental Limited has allotted equity shares under its ESOP/ESPS scheme. This corporate action updates the company's paid-up share capital.
Laxmi Dental Ltd approved the allotment of 7,911 equity shares under ESOP 2024. The board also proposed varying IPO objects and extending utilization timelines, pending shareholder approval.
Laxmi Dental reported record Q1 revenue driven by international expansion and scanner adoption, though higher operating costs and employee expenses tempered overall margin gains.